Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement

EuroIntervention

Volumn 11, Issue 8, 2015, Pages 905-913

  Van Nunen, Lokien X ^a   Lenders, Guy D ^a   Schampaert, Stéphanie ^a   Van 'T Veer, Marcel ^a   Wijnbergen, Inge ^a   Brueren, Guus R G ^a   Tonino, Pim A L ^a   Pijls, Nico H J ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

Adenosine; Coronary hyperaemia; Fractional flow reserve; Regadenoson

Indexed keywords

ADENOSINE; REGADENOSON; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BOLUS INJECTION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; DIASTOLIC BLOOD PRESSURE; DRUG SAFETY; DYSPNEA; FEMALE; FRACTIONAL FLOW RESERVE; HEART RATE; HUMAN; HYPEREMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MAXIMUM CORONARY HYPEREMIA; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RIGHT CORONARY ARTERY; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; CATHETERIZATION; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; HEART CATHETERIZATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; PREDICTIVE VALUE;

AGED; CARDIAC CATHETERIZATION; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PURINES; PYRAZOLES; REPRODUCIBILITY OF RESULTS; VASODILATOR AGENTS;

EID: 84954215715     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY14M08_10     Document Type: Article

References (18)

1. Pijls NH, De Bruyne B, Peels K, van der Voort PH, Bonnier HJ, Bartunek J, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J 'Med. 1996;334:1703-8.
2. Pijls NH, Sels JW. Functional measurement of coronary stenosis. J Am Coll Cardiol. 2012;59:1045-57.
3. Pijls NH, Tanaka N, Fearon WF. Functional assessment of coronary stenoses: can we live without it? Eur Heart J. 2013;34:1335-44.
4. De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107:1877-83.
5. Berry C, van 't Veer M, Witt N, Kala P, Bocek O, Pyxaras SA, McClure JD, Fearon WF, Barbato E, Tonino PA, De Bruyne B, Pijls NH, Oldroyd KG. VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients. J Am Coll Cardiol. 2013;61:1421-7.
6. Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mla R, Tarkin J, Petraco R, Broyd C, Jabbour R, Sethi A, Baker CS, Bellamy M, Al-Bustami M, Hackett D, Khan M, Lefroy D, Parker KH, Hughes AD, Francis DP, Di Mario C, Mayet J, Davies JE. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol. 2012;59:1392-402.
7. Jeremias A, Maehara A, Genereux P, Asrress KN, Berry C, De Bruyne B, Davies JE, Escaned J, Fearon WF, Gould KL, Johnson NP, Kirtane AJ, Koo BK, Marques KM, Nijjer S, Oldroyd KG, Petraco R, Piek JJ, Pijls NH, Redwood S, Siebes M, Spaan JA, van 't Veer M, Mintz GS, Stone GW. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting P/P with fractional flow reserve: the RESOLVE study. J Am Coll Cardiol. 2014;63:1253-61.
8. Johnson NP, Kirkeeide RL, Asrress KN, Fearon WF, Lockie T, Marques KM, Pyxaras SA, Rolandi MC, van 't Veer M, De Bruyne B, Piek JJ, Pijls NH, Redwood S, Siebes M, Spaan JA, Gould KL. Does the instantaneous wave-free ratio approximate the fractional flow reserve? J Am Coll Cardiol. 2013;61:1428-35.
9. Al Jaroudi W, Iskandrian AE. Regadenoson: a new myocar-dial stress agent. J Am Coll Cardiol. 2009;54:1123-30.
10. Arumugham P, Figueredo VM, Patel PB, Morris DL. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve. EuroIntervention. 2013;8:1166-71.
11. Nair PK, Marroquin OC, Mulukutla SR, Khandhar S, Gulati V, Schindler JT, Lee JS. Clinical utility of regadenoson for assessing fractional flow reserve. JACC Cardiovasc Interv. 2011;4:1085-92.
12. Prasad A, Zareh M, Doherty R, Gopal A, Vora H, Somma K, Mehra A, Clavijo LC, Matthews RV, Shavelle DM. Use of regaden-oson for measurement of fractional flow reserve. Catheter Cardiovasc Interv. 2014;83:369-74.
13. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928-34.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.
15. Pijls NH, Kern MJ, Yock PG, De Bruyne B. Practice and potential pitfalls of coronary pressure measurement. Catheter Cardiovasc Interv. 2000;49:1-16.
16. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation. 1990;82:1595-606.
17. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang W; ADVANCE MPI Investigators. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14: 645-58.
18. Zhao G, Messina E, Xu X, Ochoa M, Sun HL, Leung K, Shryock J, Belardinelli L, Hintze TH. Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist. J Cardiovasc Pharmacol. 2007;49: 369-75.